First Time Loading...

Probiotec Ltd
ASX:PBP

Watchlist Manager
Probiotec Ltd Logo
Probiotec Ltd
ASX:PBP
Watchlist
Price: 2.84 AUD Market Closed
Updated: May 9, 2024

Intrinsic Value

Probiotec Ltd. engages in manufacture, market and distribution of over-the-counter pharmaceuticals, complementary medicines and specialty ingredients. [ Read More ]

The intrinsic value of one PBP stock under the Base Case scenario is 3.96 AUD. Compared to the current market price of 2.84 AUD, Probiotec Ltd is Undervalued by 28%.

Key Points:
PBP Intrinsic Value
Base Case
3.96 AUD
Undervaluation 28%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Probiotec Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling PBP stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Probiotec Ltd

Provide an overview of the primary business activities
of Probiotec Ltd.

What unique competitive advantages
does Probiotec Ltd hold over its rivals?

What risks and challenges
does Probiotec Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Probiotec Ltd.

Provide P/S
for Probiotec Ltd.

Provide P/E
for Probiotec Ltd.

Provide P/OCF
for Probiotec Ltd.

Provide P/FCFE
for Probiotec Ltd.

Provide P/B
for Probiotec Ltd.

Provide EV/S
for Probiotec Ltd.

Provide EV/GP
for Probiotec Ltd.

Provide EV/EBITDA
for Probiotec Ltd.

Provide EV/EBIT
for Probiotec Ltd.

Provide EV/OCF
for Probiotec Ltd.

Provide EV/FCFF
for Probiotec Ltd.

Provide EV/IC
for Probiotec Ltd.

Show me price targets
for Probiotec Ltd made by professional analysts.

What are the Revenue projections
for Probiotec Ltd?

How accurate were the past Revenue estimates
for Probiotec Ltd?

What are the Net Income projections
for Probiotec Ltd?

How accurate were the past Net Income estimates
for Probiotec Ltd?

What are the EPS projections
for Probiotec Ltd?

How accurate were the past EPS estimates
for Probiotec Ltd?

What are the EBIT projections
for Probiotec Ltd?

How accurate were the past EBIT estimates
for Probiotec Ltd?

Compare the revenue forecasts
for Probiotec Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Probiotec Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Probiotec Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Probiotec Ltd compared to its peers.

Compare the P/E ratios
of Probiotec Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Probiotec Ltd with its peers.

Analyze the financial leverage
of Probiotec Ltd compared to its main competitors.

Show all profitability ratios
for Probiotec Ltd.

Provide ROE
for Probiotec Ltd.

Provide ROA
for Probiotec Ltd.

Provide ROIC
for Probiotec Ltd.

Provide ROCE
for Probiotec Ltd.

Provide Gross Margin
for Probiotec Ltd.

Provide Operating Margin
for Probiotec Ltd.

Provide Net Margin
for Probiotec Ltd.

Provide FCF Margin
for Probiotec Ltd.

Show all solvency ratios
for Probiotec Ltd.

Provide D/E Ratio
for Probiotec Ltd.

Provide D/A Ratio
for Probiotec Ltd.

Provide Interest Coverage Ratio
for Probiotec Ltd.

Provide Altman Z-Score Ratio
for Probiotec Ltd.

Provide Quick Ratio
for Probiotec Ltd.

Provide Current Ratio
for Probiotec Ltd.

Provide Cash Ratio
for Probiotec Ltd.

What is the historical Revenue growth
over the last 5 years for Probiotec Ltd?

What is the historical Net Income growth
over the last 5 years for Probiotec Ltd?

What is the current Free Cash Flow
of Probiotec Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Probiotec Ltd.

Financials

Balance Sheet Decomposition
Probiotec Ltd

Current Assets 72.6m
Cash & Short-Term Investments 12.8m
Receivables 34.7m
Other Current Assets 25.1m
Non-Current Assets 158.8m
PP&E 61.2m
Intangibles 84.1m
Other Non-Current Assets 13.5m
Current Liabilities 46m
Accounts Payable 30.7m
Other Current Liabilities 15.3m
Non-Current Liabilities 97.1m
Long-Term Debt 79.1m
Other Non-Current Liabilities 18m
Efficiency

Earnings Waterfall
Probiotec Ltd

Revenue
221.2m AUD
Cost of Revenue
-155m AUD
Gross Profit
66.3m AUD
Operating Expenses
-46.2m AUD
Operating Income
20m AUD
Other Expenses
-11.3m AUD
Net Income
8.7m AUD

Free Cash Flow Analysis
Probiotec Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

PBP Profitability Score
Profitability Due Diligence

Probiotec Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
55/100
Profitability
Score

Probiotec Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.

PBP Solvency Score
Solvency Due Diligence

Probiotec Ltd's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Low D/E
Average Altman Z-Score
37/100
Solvency
Score

Probiotec Ltd's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PBP Price Targets Summary
Probiotec Ltd

Wall Street analysts forecast PBP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PBP is 3.06 AUD with a low forecast of 3.03 AUD and a high forecast of 3.15 AUD.

Lowest
Price Target
3.03 AUD
7% Upside
Average
Price Target
3.06 AUD
8% Upside
Highest
Price Target
3.15 AUD
11% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

PBP Price
Probiotec Ltd

1M 1M
-2%
6M 6M
+13%
1Y 1Y
+11%
3Y 3Y
+45%
5Y 5Y
+84%
10Y 10Y
+679%
Annual Price Range
2.84
52w Low
2.18
52w High
2.93
Price Metrics
Average Annual Return 10.07%
Standard Deviation of Annual Returns 15.12%
Max Drawdown -13%
Shares Statistics
Market Capitalization 231m AUD
Shares Outstanding 81 323 400
Percentage of Shares Shorted
N/A

PBP Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Probiotec Ltd Logo
Probiotec Ltd

Country

Australia

Industry

Pharmaceuticals

Market Cap

231m AUD

Dividend Yield

2.46%

Description

Probiotec Ltd. engages in manufacture, market and distribution of over-the-counter pharmaceuticals, complementary medicines and specialty ingredients. The company is headquartered in Melbourne, Victoria. The company went IPO on 2006-11-14. The firm owns approximately six manufacturing facilities in Australia and distributes its products both domestically and internationally. The Company’s products are manufactured on behalf of a range of clients, including international companies. The company also owns Multipack-LJM business, a contract packer, providing packing services for a range of pharmaceutical, consumer healthcare, cosmetics and food, and beverage companies. The firm subsidiaries include Probiotec Pharmaceuticals Pty Ltd, Probiotec Pharma Pty Ltd, Biotech Pharmaceuticals Australia Pty Ltd, Biotech Pharmaceuticals Pty Ltd, Probiotec (NSW) Pty Ltd, Australian Dairy Proteins Pty Ltd, Milton Pharmaceuticals Pty Ltd and Willie Labs Generics Pty Ltd.

Contact

VICTORIA
Melbourne
83 Cherry Lane, Laverton North
+61392787555.0
http://www.probiotec.com.au/

IPO

2006-11-14

Employees

-

Officers

CEO, MD & Executive Director
Mr. Wesley Stringer B.Comm, CPA, LLB (Hons)
CFO, Company Secretary & Financial Controller
Mr. Jared Stringer B.Comm, BIT, CPA
Chief Operating Officer
Ms. Julie McIntosh
Chief People Officer
Ms. Annalinde Nickisch
Chief Customer Officer
Ms. Jessica Walters
General Manager of Accounting
Mr. Alan Hong

See Also

Discover More
What is the Intrinsic Value of one PBP stock?

The intrinsic value of one PBP stock under the Base Case scenario is 3.96 AUD.

Is PBP stock undervalued or overvalued?

Compared to the current market price of 2.84 AUD, Probiotec Ltd is Undervalued by 28%.